Health Canada drug identification number

DIN 02322323 — SANDOZ NARATRIPTAN 2.5 MG

SANDOZ NARATRIPTAN is a tablet of Naratriptan marketed by SANDOZ CANADA INCORPORATED. The full Naratriptan monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02322323
Brand name
SANDOZ NARATRIPTAN
Active ingredient
Naratriptan
Strength
2.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
SANDOZ CANADA INCORPORATED
Health Canada status
MARKETED
Drug class
Selective serotonin 5-HT1B/1D receptor agonist (triptan)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Naratriptan products

DINBrandStrengthFormManufacturerStatus
02314290 TEVA-NARATRIPTAN 1 MG TABLET TEVA CANADA LIMITED MARKETED
02314304 TEVA-NARATRIPTAN 2.5 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.